We invite you to join this virtual event hosted by the Markey Cancer Center Affiliate Network and UK HealthCare Pharmacy Services.
2nd Annual Hematology & Oncology Pharmacy Symposium
Friday, September 17, 2021, 8:30 a.m. to 4:15 p.m. EDT
The purpose of this symposium is to educate pharmacists on recent innovations in the field of hematology and oncology, as well as provide an opportunity to collaborate with colleagues on contemporary changes in oncology pharmacy.
For more information visit our LIVE CECentral page at https://www.cecentral.com/live/20992
UK HealthCare CECentral exists to provide healthcare teams continuing professional development activities that increase knowledge, competence and performance levels leading to better patient care, improved patient safety, enhanced clinical outcomes and improved community health.
8:30 a.m. – 8:35 a.m. Welcome and Announcements
Amber Lawson, PharmD, BCOP
Contemporary Issues in Pharmacy Practice Management
8:35 a.m. – 9:30 a.m. Oncology Med Management at Home: Elevating the Role of the Pharmacist in Clinical Pathways
Bob Gold, MS
- Describe how to use digital therapeutics to practice at top of license and efficiently engage physicians and nurses.
- Discuss how understanding the whole person (Mind-Body) improves precision medication strategies.
- Define how to be informed of potential medication adverse events before they happen.
- Detail how to make family caregivers more effective in keeping patients on therapy.
9:30 a.m. – 10:15 a.m. The Down and Dirty on Negative Pressure Clean Rooms: A Technical Review of Facility and Engineering Controls to Optimize USP Compliance
Philip Schwieterman, PharmD, MHA
- Discuss facility controls required to compound hazardous drugs.
- Review technical details of primary and secondary engineering controls and their impact on air handling systems.
- Present real-life scenarios and hurdles to the design, build, and maintenance of negative pressure compounding rooms.
10:15 – 10:30 a.m. Break/Exhibits
10:30 a.m. –11:15 a.m. Pharmacy Reimbursement & Denials Oversight Program Opportunities
Cathy Whalen, PharmD
- Develop a basic oversight program to monitor drug inventory, drug costs and charges vs reimbursement.
- Develop a financial dashboard for monthly trending purposes
- Establish a process to review top high-cost drug reimbursement
- Develop a proactive denials/pharmacy team to review common errors contributing to payor denials.
11:15 a.m. –12:00 p.m. EHR Conversions: What Pharmacists Need to Know
Brandon Green, PharmD
Amy Gibson, PharmD, MPH, BCPS
- Identify a process for successful conversion of an Electronic Health Record (EHR)
- Describe pharmacist roles in EHR implementation and maintenance and the impact on patient safety.
12:00 – 1:00 p.m. Lunch Break/Exhibits
Innovations in Hematology & Oncology Clinical Practice
1:00 p.m. –2:00 p.m. Pharmacist Perspective: Best of ASCO 2021
Val Adams, PharmD, FCCP, FHOPA, BCOP
- Identify recently presented efficacy data that may impact patient treatment.
- Determine which patient populations should be considered for these new treatment approaches.
- Recognize the potential toxicity associated with these new treatments.
2:00 p.m. –3:00 p.m. “Dara” to Challenge the Status Quo: The Changing Landscape of Myeloma Treatment
Anna Hitron, PharmD, MS, MBA, BCOP
Beth Travers, PharmD, BCOP
- Assess the patient specific factors that impact the use of daratumumab combinations in the first-line setting
- Evaluate the impact of maintenance therapy on patient outcomes in the transplant ineligible population
- Discuss the benefits and risks of CAR-T in comparison to HSCT in the treatment of multiple myeloma
3:00 – 3:15 p.m. Break/Exhibits
3:15 p.m. – 4:15 p.m. Oral Chemotherapy Best Practices:
Oral Chemo Dosage Adjustments
Oral Chemotherapy Clinical Pearls in AML
Megan May, PharmD, BCOP
Rob Walchack, PharmD, BCOP
4:15 p.m. Closing Remarks
Philip Schwieterman, PharmD, MHA